Pooled Testing for Surveillance of SARS-CoV-2 in Asymptomatic Individuals

[1]  Meei-Li W Huang,et al.  Pooling of SARS-CoV-2 samples to increase molecular testing throughput , 2020, Journal of Clinical Virology.

[2]  Zachary Schiffman,et al.  Predicting infectious SARS-CoV-2 from diagnostic samples , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  D. Raoult,et al.  Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards , 2020, European Journal of Clinical Microbiology & Infectious Diseases.

[4]  S. Hinrichs,et al.  Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources , 2020, American journal of clinical pathology.

[5]  Christopher R Bilder,et al.  Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources , 2020, medRxiv.

[6]  B. Pinsky,et al.  Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2. , 2020, JAMA.

[7]  Joshua M Tebbs,et al.  The objective function controversy for group testing: Much ado about nothing? , 2019, Statistics in medicine.

[8]  S. West,et al.  Evaluation of pooled ocular and vaginal swabs by the Cepheid GeneXpert CT/NG assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae compared to the GenProbe Aptima Combo 2 Assay. , 2015, Diagnostic microbiology and infectious disease.

[9]  Christopher S. McMahan,et al.  Informative Dorfman Screening , 2012, Biometrics.

[10]  David M. Warshauer,et al.  Pooling Nasopharyngeal/Throat Swab Specimens To Increase Testing Capacity for Influenza Viruses by PCR , 2011, Journal of Clinical Microbiology.